Business Context and Reporting Period
This Form 8-K filing by Aikido Pharma Inc. (not Dominari Holdings Inc.) reports on the Annual Meeting of Stockholders held on May 20, 2022. The registrant is a Delaware corporation with common stock trading on the Nasdaq Capital Market under the symbol AIKI.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Stockholders approved four key proposals at the Annual Meeting:
- Election of Directors: Anthony Hayes and Robert Dudley were elected as Class II directors.
- Accounting Firm Ratification: WithumSmith + Brown PC was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
- Executive Compensation: The Company's executive compensation was approved via a non-binding advisory vote.
- Reverse Stock Split: Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split. The ratio will be between 1-for-5 and 1-for-30, determined by the Board of Directors. The effective date is set for June 7, 2022.
Voting Statistics:
| Proposal | Votes For | Votes Against | Abstentions |
|---|---|---|---|
| Election of Directors (Hayes) | 12,213,453 | 4,159,661 (Withheld) | - |
| Election of Directors (Dudley) | 10,958,821 | 5,414,293 (Withheld) | - |
| Ratification of Auditor | 38,313,371 | 2,802,590 | 612,197 |
| Executive Compensation | 9,376,680 | 6,666,153 | 330,281 |
| Reverse Stock Split | 296,337,689 | 86,157,071 | 233,398 |
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The primary operational change is the authorized reverse stock split, which will alter the share count and potentially the trading price per share effective June 7, 2022.
Investor Verification Checklist
- Verify the exact reverse stock split ratio once announced by the Board of Directors (range: 1-for-5 to 1-for-30).
- Confirm the effective date of the reverse stock split (June 7, 2022) and its impact on share ownership and trading.
- Review the significant number of votes withheld against director Robert Dudley (approx. 33% of votes cast).
- Check subsequent filings for the updated share count post-split.